In silico evaluation of (benzo)chromeno[3,4-c]pyridine derivative as dual EGFR/HER2 inhibitors for non-small cell lung cancer

U Uduak Luke I Innocent E. Emeng N Nguuma I. Gber S Solomon O. Iyam

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 23, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (4)

U

Uduak Luke

I

Innocent E. Emeng

N

Nguuma I. Gber

S

Solomon O. Iyam